Danielle H. Tangorre discusses key takeaways for labs from the DOJ’s recent nationwide takedown of $1.2 billion in alleged schemes.
Lab Compliance Advisor
Practical, “What-to-Do” and “How-to-Do-It” Help to Comply with the Latest State & Federal Laws, Rules & Regulations that Affect Your Diagnostic Lab or Pathology Practice
Subscribe today for full access
to all of these articles.
In this month’s Labs in Court roundup, BioReference pays big to settle kickback allegations, among several other kickback-related cases.
D.C. Circuit Court of Appeals agrees with lab industry that CMS got Medicare lab pricing all wrong, but says it’s unable to intervene.
The OIG’s new Fraud Alert can help labs and other providers steer clear of potentially suspect arrangements with telemedicine companies.
Use of these codes has frequently raised concerns for compliance due to a lack of clarity regarding when they’re appropriate.
While this reimbursement rule has been in effect since 2018, it can still be quite confusing; this article provides a guide to the basics.
In this month’s Labs in Court roundup, Arrayit’s former president loses his bid to have EKRA charges dismissed, and more.
While rules differ by state, the basic measures required to protect employees from workplace violence are pretty much the same everywhere.
Part of the duty to protect workers is to ensure those at risk receive proper training on what to do if an active shooter incident occurs.
Legal team’s bid to dismiss part of CMS inspector’s testimony as hearsay is denied by the Northern District of California federal court.
What happens when lab personnel’s OSHA rights to access illness and injury records seemingly clash with HIPAA privacy laws?
New OIG Advisory Opinion offers valuable insight into where the agency draws the line on free genetic tests.